FULGENT GENETICS, INC. Lessor, Operating Lease, Payments to be Received
FULGENT GENETICS, INC. (FLGT) had Lessor, Operating Lease, Payments to be Received of $0 as of 2025-03-31, per its 10-Q filed 2025-05-02.
Financial Statements › Notes › Leases
us-gaap:LessorOperatingLeasePaymentsToBeReceived · last filed 2025-05-02
- 2025-03-31: Lessor, Operating Lease, Payments to be Received $0.00.
- 2024-12-31: Lessor, Operating Lease, Payments to be Received $0.00.
- 2024-03-31: Lessor, Operating Lease, Payments to be Received $68.00K.
- 2023-12-31: Lessor, Operating Lease, Payments to be Received $90.00K.
| Period end | Lessor, Operating Lease, Payments to be Received |
|---|---|
| 2025-03-31 | $0.00 10-Q · filed 2025-05-02 |
| 2024-12-31 | $0.00 10-K · filed 2025-02-28 |
| 2024-03-31 | $68.00K 10-Q · filed 2024-05-03 |
| 2023-12-31 | $90.00K 10-K · filed 2024-02-28 |
| 2023-09-30 | $126.00K 10-Q · filed 2023-11-03 |
| 2023-06-30 | $162.00K 10-Q · filed 2023-08-04 |
| 2023-03-31 | $230.00K 10-Q · filed 2023-05-05 |
| 2022-12-31 | $275.00K 10-K · filed 2023-02-28 |
| 2022-09-30 | $136.00K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $728.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $830.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $919.00K 10-K · filed 2022-02-28 |
| 2021-09-30 | $1.07M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $440.00K 10-Q · filed 2021-08-10 |
| 2021-03-31 | $520.00K 10-Q · filed 2021-05-07 |
| 2020-12-31 | $681.00K 10-K · filed 2021-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |